Studies on pharmacokinetics and bioequivalence of telmisartan in healthy volunteers
Yan Zhou
Abstract
Yan Zhou
Abstract
OBJECTIVE To study the pharmacokinetics profiles of telmisartan and observe the bioavailability of domestic telmisartan tablet and capsule METHODS A triple cross experiment design was conducted 18 healthy volunteers were given a single dose of 80 mg telmisartan after divided into 3 groups randomly The wash out period was 12 d HPLC method was applied to analyze telmisartan concentration in plasma RESULTS The main pharmacokinetics parameters of three preparations(tablet,capsule and reference) were as follow: c max were(812 16±110 65),(819 54±129 97)and(855 37±92 27)ng·mL -1 ; t max were(0 99±0 43),(0 83±0 36)and(1 15±0 61)h; t 1/2 were(19 3±7 0),(19 5±2 9)and(18 6±3 9)h;AUC 0~72 were (4 181 43±2 536 14),(3 785 63±2 477 71)and(3 874 48± 1 981 11 )ng·h·mL -1 , respectively The bioavailability of tablet and capsule were (106 87±16 17)% and(97 69±20 65)%, respectively CONCLUSION The pharmacokinetic figures were weighed with ANOVA,two one sided t test and 90% confidence interval and the results showed the two domestics preparations were both bioequivalent compared with the imported tablet
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics profiles of telmisartan and observe the bioavailability of domestic telmisartan tablet and capsule METHODS A triple cross experiment design was conducted 18 healthy volunteers were given a single dose of 80 mg telmisartan after divided into 3 groups randomly The wash out period was 12 d HPLC method was applied to analyze telmisartan concentration in plasma RESULTS The main pharmacokinetics parameters of three preparations(tablet,capsule and reference) were as follow: c max were(812 16±110 65),(819 54±129 97)and(855 37±92 27)ng·mL -1 ; t max were(0 99±0 43),(0 83±0 36)and(1 15±0 61)h; t 1/2 were(19 3±7 0),(19 5±2 9)and(18 6±3 9)h;AUC 0~72 were (4 181 43±2 536 14),(3 785 63±2 477 71)and(3 874 48± 1 981 11 )ng·h·mL -1 , respectively The bioavailability of tablet and capsule were (106 87±16 17)% and(97 69±20 65)%, respectively CONCLUSION The pharmacokinetic figures were weighed with ANOVA,two one sided t test and 90% confidence interval and the results showed the two domestics preparations were both bioequivalent compared with the imported tablet
Key concepts: Telmisartan, Bioequivalence, Pharmacokinetics, Bioavailability, Capsule, Pharmacology, Confidence interval, Medicine